MYMD PHARMACEUTICALS INC's ticker is and the CUSIP is 62856X102. A total of 51 filers reported holding MYMD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 4.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $556,836 | -68.6% | 940,602 | -20.5% | 0.00% | -75.0% |
| Q2 2023 | $1,775,425 | -12.0% | 1,183,616 | +0.9% | 0.00% | -20.0% |
| Q1 2023 | $2,018,609 | +132.0% | 1,173,610 | +55.1% | 0.01% | +150.0% |
| Q4 2022 | $869,958 | -47.8% | 756,485 | +18.5% | 0.00% | -50.0% |
| Q3 2022 | $1,667,000 | -28.5% | 638,580 | -40.5% | 0.00% | -33.3% |
| Q2 2022 | $2,330,000 | -54.3% | 1,073,765 | -2.0% | 0.01% | +20.0% |
| Q1 2022 | $5,104,000 | +10.2% | 1,095,418 | +43.3% | 0.01% | -50.0% |
| Q4 2021 | $4,631,000 | -43.2% | 764,245 | -32.5% | 0.01% | -52.4% |
| Q3 2021 | $8,151,000 | – | 1,132,131 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Shay Capital LLC | 321,187 | $1,497,000 | 0.19% |
| Corundum Group, Inc. | 19,600 | $91,000 | 0.08% |
| Ikarian Capital, LLC | 131,389 | $612,000 | 0.08% |
| M Holdings Securities, Inc. | 70,909 | $330,000 | 0.02% |
| 683 Capital Management, LLC | 59,410 | $277,000 | 0.02% |
| Western Wealth Management, LLC | 30,713 | $143,000 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 1,095,418 | $5,104,000 | 0.01% |
| Qube Research & Technologies Ltd | 20,896 | $97,000 | 0.00% |
| MORGAN STANLEY | 908,576 | $4,234,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 13,690 | $64,000 | 0.00% |